Content about Dow Jones Industrial Average

February 22, 2012

Johnson & Johnson on Tuesday named Alex Gorsky CEO of the company, effective April 26, the date of the company’s annual meeting of shareholders.

NEW BRUNSWICK, N.J. — Johnson & Johnson on Tuesday named Alex Gorsky CEO of the company, effective April 26, the date of the company’s annual meeting of shareholders. Gorsky also has been nominated for election to the board of directors at the meeting.

February 21, 2012

Pfizer has signed a deal worth more than $500 million with a Chinese drug maker to make generic drugs for China and other markets, the companies said.

NEW YORK — Pfizer has signed a deal worth more than $500 million with a Chinese drug maker to make generic drugs for China and other markets, the companies said.

Pfizer announced the joint venture with Zhejiang Hisun Pharmaceutical to develop, manufacture and commercialize generic drugs. Hisun will invest $295 million into the venture — called Hisun Pfizer Pharmaceutical Co. — and own a 51% stake, while Pfizer will invest $250 million and own 49%.

February 17, 2012

A specialty pharmacy provider has begun selling a drug made by Pfizer for treating kidney cancer.

ALTAMONTE SPRINGS, Fla. — A specialty pharmacy provider has begun selling a drug made by Pfizer for treating kidney cancer.

The company announced that it had launched Inlyta (axitinib), which the Food and Drug Administration approved last month for treating renal cell carcinoma in patients with advanced disease for whom first-line systemic therapy has failed. According to the American Cancer Society, 60,000 people in the United States are diagnosed with the disease each year, and 13,000 die.

February 15, 2012

The Food and Drug Administration will review a regulatory approval application from Pfizer for a drug to treat an extremely rare and fatal degenerative disease, Pfizer said Wednesday.

NEW YORK — The Food and Drug Administration will review a regulatory approval application from Pfizer for a drug to treat an extremely rare and fatal degenerative disease, Pfizer said Wednesday.

Pfizer announced that the FDA had accepted its application for tafamidis meglumine, a treatment for transthyretin familial amyloid polyneuropathy. The disease, also known as TTR-FAP, is a fatal genetic illness that affects about 8,000 people worldwide and causes severe sensory loss, pain, weakness and organ dysfunction.

February 15, 2012

Managed care and prescription plans are working to switch patients to generic versions of Pfizer's Lipitor despite the drug maker's efforts to reduce costs for the branded version, a new study suggested.

PHOENIX — Managed care and prescription plans are working to switch patients to generic versions of Pfizer's Lipitor despite the drug maker's efforts to reduce costs for the branded version, a new study suggested.

According to a report released Wednesday by Wolters Kluwer Pharma Solutions' inThought research group, while Lipitor (atorvastatin) has 41% of the market share of all dispensed prescriptions of atorvastatin, it has 35% of the payer approval volume.

February 14, 2012

Procter & Gamble has teamed up with a nonprofit to promote the environmental and energy savings benefits of washing laundry in cold water.

CINCINNATI — Procter & Gamble has teamed up with a nonprofit to promote the environmental and energy savings benefits of washing laundry in cold water.

February 8, 2012

Walmart isn’t about to let the grass grow under its feet in Canada.

MISSISSAUGA, Ontario — Walmart isn’t about to let the grass grow under its feet in Canada. The discounter plans to spend about $753 million this fiscal year to expand its store presence in Canada, before rival Target begins its push in the country.

February 7, 2012

A drug under development by Merck "significantly" reduced the risk of heart attack, stroke and cardiovascular death in patients, according to clinical trial results announced Tuesday.

WHITEHOUSE STATION, N.J. — A drug under development by Merck "significantly" reduced the risk of heart attack, stroke and cardiovascular death in patients, according to clinical trial results announced Tuesday.

February 2, 2012

The Food and Drug Administration has approved a drug made by Merck for Type 2 diabetes, the drug maker said Thursday.

WHITEHOUSE STATION, N.J. — The Food and Drug Administration has approved a drug made by Merck for Type 2 diabetes, the drug maker said Thursday.

Merck announced the approval of Janumet XR (sitagliptin and metformin hydrochloride) extended-release tablets as a once-daily treatment for the disease.

February 1, 2012

Procter & Gamble and comedian Larry the Cable Guy on Wednesday awarded a pair of Super Bowl tickets to three winners of the Prilosec OTC "A Better Way to Tailgate" challenge.

CINCINNATI — Procter & Gamble and comedian Larry the Cable Guy on Wednesday awarded a pair of Super Bowl tickets to three winners of the Prilosec OTC "A Better Way to Tailgate" challenge.

Participants submitted photos showcasing creative tailgate set-ups and food spreads, along with a recipe to accompany their “food spread” entry, to TailgateFan.com/contest.

January 27, 2012

The Food and Drug Administration has approved a drug made by Pfizer for treating advanced kidney cancer, the agency said Friday.

SILVER SPRING, Md. — The Food and Drug Administration has approved a drug made by Pfizer for treating advanced kidney cancer, the agency said Friday.

The FDA announced the approval of Inlyta (axitinib) for patients with advanced kidney cancer, also known as renal cell carcinoma, who have not responded to another drug for the disease. The drug, a twice-daily pill, works by blocking certain proteins called kinases that are involved with tumor growth and disease progression.

January 27, 2012

Procter & Gamble announced on Friday that second-quarter net sales and organic sales rose 4% as net earnings dropped 49%.

CINCINNATI — Procter & Gamble announced on Friday that second-quarter net sales and organic sales rose 4% as net earnings dropped 49%.

January 26, 2012

Pfizer is partnering with a division of Johnson & Johnson and a charity organization to launch an initiative to award funding to projects designed to improve the diagnostic identification and tracking of Alzheimer's disease.

NEW YORK — Pfizer is partnering with a division of Johnson & Johnson and a charity organization to launch an initiative to award funding to projects designed to improve the diagnostic identification and tracking of Alzheimer's disease.

January 26, 2012

Walmart on Wednesday opened its second supercenter in Chicago.

NEW YORK — Walmart on Wednesday opened its second supercenter in Chicago.

January 25, 2012

Johnson & Johnson is preparing to turn the corner with its McNeil Consumer Healthcare business, J&J chairman and CEO William Weldon told analysts during the company's fourth-quarter earnings call Tuesday.

NEW BRUNSWICK, N.J. — Johnson & Johnson is preparing to turn the corner with its McNeil Consumer Healthcare business, J&J chairman and CEO William Weldon told analysts during the company's fourth-quarter earnings call Tuesday. That over-the-counter business generated $5.2 billion in the United States for the year ended Jan. 2, representing a 6.7% decline as compared to 2010.

January 20, 2012

In an unexpected turn of events, Brian Cornell is stepping down as Sam’s Club president and CEO and will be replaced by Rosalind Brewer, who currently serves as president of the Walmart U.S. East business unit.

BENTONVILLE, Ark. — In an unexpected turn of events, Brian Cornell is stepping down as Sam’s Club president and CEO and will be replaced by Rosalind Brewer, who currently serves as president of the Walmart U.S. East business unit. The company announced a number of other senior personnel changes as well in advance of the new fiscal year.

In a statement, Walmart said Cornell, 52, recently informed the company that he and his wife would like to move back to the Northeast for family reasons. His departure comes as Sam’s has experienced strong sales growth.

January 19, 2012

Looking to put America's inventors front and center by uncovering the next great product, Walmart and @WalmartLabs have kicked off the "Get on the Shelf" contest.

SAN BRUNO, Calif. — Looking to put America's inventors front and center by uncovering the next great product, Walmart and @WalmartLabs have kicked off the "Get on the Shelf" contest.

January 11, 2012

On Tuesday, IBM released its final benchmark announcement for the 2011 holiday season, detailing a continued strong performance for mobile, as well as an overall increase in online spending for December 2011.

ARMONK, N.Y. — On Tuesday, IBM released its final benchmark announcement for the 2011 holiday season, detailing a continued strong performance for mobile, as well as an overall increase in online spending for December 2011.

According to the report, the U.S. online retail sector delivered 7.5% growth in December 2011, compared with the same period last year. This followed a strong November where both Black Friday 2011 and Cyber Monday 2011 delivered double-digit growth over 2010.

Other key findings of the IBM report included:

January 4, 2012

U.S. Preventive Medicine on Wednesday named Ronald Loveless its vice chairman.

DALLAS — U.S. Preventive Medicine on Wednesday named Ronald Loveless its vice chairman. Loveless will serve alongside vice chairman Ron Loeppke, who joined the company in 2008 to direct product innovation, research and clinical standards at the company.

Loveless, a Walmart retiree and first CEO of Sam's Club, will play a key role in guiding the growth of U.S. Preventive Medicine in the United States, as well as international markets, the company stated.

January 3, 2012

The Food and Drug Administration has approved a Pfizer vaccine for Streptococcus pneumoniae in adults ages 50 years and older, the company said.

NEW YORK — The Food and Drug Administration has approved a Pfizer vaccine for Streptococcus pneumoniae in adults ages 50 years and older, the company said.

Pfizer announced the FDA approval of Prevnar 13 (pneumococcal 13-valent conjugate vaccine [diphtheria CRM197 protein]) as a single-dose for adults.

December 22, 2011

A Pfizer painkiller appears to produce a much less positive experience for recreational drug users when crushed than when administered whole, according to results of a post-marketing clinical study program.

NEW YORK — A Pfizer painkiller appears to produce a much less positive experience for recreational drug users when crushed than when administered whole, according to results of a post-market clinical study program.

December 19, 2011

Nielsen Holdings on Monday announced that Rick Kash has been appointed vice chair and will join CEO David Calhoun and vice chair Susan Whiting in the office of the CEO. Nielsen also named Mitchell Habib COO.

NEW YORK — Nielsen Holdings on Monday announced that Rick Kash has been appointed vice chair and will join CEO David Calhoun and vice chair Susan Whiting in the office of the CEO. Nielsen also named Mitchell Habib COO.

December 16, 2011

A drug made by Pfizer shows "significant" benefit to patients with restless legs syndrome, according to results of a late-stage clinical trial announced Friday.

NEW YORK — A drug made by Pfizer shows "significant" benefit to patients with restless legs syndrome, according to results of a late-stage clinical trial announced Friday.

The drug maker said Lyrica (pregabalin) produced statistically significant improvements in patients with RLS compared with placebo and pramipexole after 12 weeks of treatment. In the phase-3 study, A0081186, 300 mg of Lyrica, 0.25 mg of pramipexole, 0.5 mg of pramipexole or placebo was given to patients on a daily basis.

December 13, 2011

Procter & Gamble announced Tuesday that Gain would be partnering with comedienne and actress Wanda Sykes, who will join Gain’s resident “Scenthropologist” Tim Hittle in promoting Gain’s 13 detergents and fabric softener scents.

Procter & Gamble announced Tuesday that Gain would be partnering with comedienne and actress Wanda Sykes, who will join Gain’s resident “Scenthropologist” Tim Hittle in promoting Gain’s 13 detergents and fabric softener scents.

December 8, 2011

A Food and Drug Administration panel of 13 advisers has voted in favor of a drug made by Pfizer for treating kidney cancer, the drug maker said Wednesday.

NEW YORK — A Food and Drug Administration panel of 13 advisers has voted in favor of a drug made by Pfizer for treating kidney cancer, the drug maker said Wednesday.

Pfizer announced that the FDA's Oncologic Drugs Advisory Committee voted unanimously to state that axitinib's benefits outweighed its risks in patients with advanced renal cell carcinoma for whom first-line treatments had failed.